{"date": "2022-01-28 22:37:20.549000+00:00", "ticker": "III", "mrkt_info": {"open": 1347.0, "close": 1370.0}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-lead\"><p>Temasek Holdings Limited, a Singapore-based investment company, has acquired Element Materials Technology Group Limited, a provider of destructive and non-destructive testing, inspection, and certification (TIC) services for metals and non-metals, from Bridgepoint Group Plc, a private investment company. Element Materials and Bridgepoint are based in the UK</p><p>Prior to the transaction, Temasek is a minority shareholder in Element Materials</p></div><div class=\"tr-npp-body\"><p class=\"tr-npp-section-title\">Deal In Brief</p><p>Element Materials was advised by Bank of America Securities, Goldman Sachs and Rothschild &amp; Co (M&amp;A), Allen &amp; Overy LLP (legal), Ernst &amp; Young Global Ltd (finance and tax), The Boston Consulting Group (commercial), DLA Piper LLP, Jamieson and PwC (management advisors)</p><p>The transaction remains subject to customary regulatory approvals</p><p>Deal History: Rumor: On January 24, 2022, According to Reuters, Temasek is acquiring Element Materials from Bridgepoint for about USD7 billion.</p><div class=\"story-table-container\"><table class=\"story-basic-table\"><tbody><tr><td>Deal Type</td><td>Private Equity</td> </tr><tr><td>Sub-Category</td><td>Institutional Buy-out (IBO)</td> </tr><tr><td>Deal Status</td><td>Completed: 2022-01-25</td> </tr> </tbody> </table></div><p class=\"tr-npp-section-title\">Deal Participants</p><div class=\"story-table-container\"><table class=\"story-basic-table\"><tbody><tr><td>Target (Company)</td><td>Element Materials Technology Group Holdings Ltd</td> </tr><tr><td>Acquirer (Company)</td><td>Temasek Holdings (Private) Limited</td> </tr><tr><td>Vendor (Company)</td><td>Bridgepoint Group plc</td> </tr> </tbody> </table></div><p class=\"tr-npp-section-title\">Deal Rationale</p><p><span>(Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Marketline shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon.)</span> </p></div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright \u00a9 2001 Marketline. All rights reserved.</p></div>"}